Product Information

OLOPATADINE HCL 0.2% EYE DROP is a generic product labeled by BluePoint Laboratories, priced at $2.9978 per ML under NDC 68001067492. Its NADAC has been published 49 times since Dec 17, 2025.

FDA first approved this application on Feb 28, 2025.

OLOPATADINE HCL 0.2% EYE DROP

OLOPATADINE HYDROCHLORIDE
$2.9978per ML
OTC

Strength

2 mg/mL

NDC

68001067492

Classification

Generic

Dosage Form

SOLUTION

Route

OPHTHALMIC

Effective Date

11/18/2026

Active Ingredients

OLOPATADINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA219557

FDA Approved

2/28/2025

On Market Since

9/15/2025

Pharmacological Classes

Decreased Histamine Release
Histamine H1 Receptor Antagonists
Histamine-1 Receptor Antagonist
Histamine-1 Receptor Inhibitor
Mast Cell Stabilizer

Price Statistics

The NADAC for OLOPATADINE HCL 0.2% EYE DROP has been published 49 times since Dec 17, 2025, and over the history we have for it it has declined 11.7%. The table below summarizes its recorded NADAC range and movement.

Current price$2.9978 per ML
All-time high$3.3966 (Jan 14, 2026)
All-time low$2.9636 (Sep 23, 2026)
52-week high$3.3966
52-week low$2.9636
Median price$3.0962
Average price$3.1302
Largest weekly change-3.3% (Jun 17, 2026)
Weeks tracked49
Tracking sinceDec 17, 2025

Price History

1W

+0.6%

1M

+1.2%

3M

+0.0%

6M

-3.2%

1Y

N/A

3Y

N/A

5Y

N/A

All

-11.7%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 31% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of OLOPATADINE HCL 0.2% EYE DROP?

The current National Average Drug Acquisition Cost (NADAC) for OLOPATADINE HCL 0.2% EYE DROP, manufactured by BluePoint Laboratories, is $2.9978 per ML (NDC 68001067492), effective Nov 18, 2026.

How has the price of OLOPATADINE HCL 0.2% EYE DROP changed over time?

Over the history we have for it, the NADAC for OLOPATADINE HCL 0.2% EYE DROP has declined 11.7%. It has been tracked across 49 weekly CMS publications since Dec 17, 2025.

What are the highest and lowest recorded NADAC prices for OLOPATADINE HCL 0.2% EYE DROP?

Since Dec 17, 2025, the NADAC for OLOPATADINE HCL 0.2% EYE DROP has ranged from a low of $2.9636 (Sep 23, 2026) to a high of $3.3966 (Jan 14, 2026), with a median of $3.0962 per ML.

Are there cheaper alternatives to OLOPATADINE HCL 0.2% EYE DROP?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OLOPATADINE HCL 0.2% EYE DROP, is $2.0721 per ML — about 31% below OLOPATADINE HCL 0.2% EYE DROP.

Who manufactures OLOPATADINE HCL 0.2% EYE DROP?

OLOPATADINE HCL 0.2% EYE DROP (NDC 68001067492) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.